- Research Article
- 10.1007/s11884-025-00797-3
- Dec 1, 2025
- Current Bladder Dysfunction Reports
- Fentas Anastasios + 3 more
- Research Article
- 10.1007/s11884-025-00796-4
- Dec 1, 2025
- Current Bladder Dysfunction Reports
- Colby Rondeau + 3 more
- Research Article
- 10.1007/s11884-025-00789-3
- Dec 1, 2025
- Current Bladder Dysfunction Reports
- Bailey C Smith + 5 more
Abstract Purpose of Review Overactive bladder (OAB) and poorly compliant bladder are two urologic conditions that share overlapping symptoms, such as urinary frequency and incontinence, but arise from distinct etiologies. This review briefly outlines their pathophysiology and summarizes current management strategies. Recent Findings OAB is a clinical diagnosis defined by the hallmark symptom of urgency, whereas poorly compliant bladder is a urodynamic finding characterized by elevated storage pressures that can threaten upper tract function, leading to stone formation, recurrent urinary tract infections, and renal insufficiency. Initial management of OAB begins with behavioral therapy, followed by pharmacologic treatment. The two main classes are antimuscarinics and β3-agonists. Minimally invasive therapies, including onabotulinumtoxinA and neuromodulation, represent subsequent options. When conservative and minimally invasive treatments fail, surgical options such as augmentation cystoplasty or ileal conduit diversion may be considered. Summary Current management focuses on symptom relief in OAB and stabilization of bladder pressures in poorly compliant bladder. Emerging therapies—including repetitive transcranial magnetic stimulation (rTMS) for OAB and antifibrotics, anti-inflammatory agents, and stem cell-based approaches for poorly compliant bladder—are under investigation, with the potential to restore bladder function through tissue regeneration.
- Research Article
- 10.1007/s11884-025-00792-8
- Dec 1, 2025
- Current Bladder Dysfunction Reports
- Juan Francisco Penafiel + 2 more
- Research Article
- 10.1007/s11884-025-00791-9
- Dec 1, 2025
- Current Bladder Dysfunction Reports
- Emily Polley + 4 more
- Research Article
- 10.1007/s11884-025-00802-9
- Dec 1, 2025
- Current Bladder Dysfunction Reports
- Wan-Ru Yu + 1 more
- Research Article
- 10.1007/s11884-025-00794-6
- Dec 1, 2025
- Current Bladder Dysfunction Reports
- David Hernández-Hernández + 2 more
- Research Article
- 10.1007/s11884-025-00795-5
- Nov 26, 2025
- Current Bladder Dysfunction Reports
- Rochelle Kofman + 1 more
- Research Article
- 10.1007/s11884-025-00787-5
- Nov 26, 2025
- Current Bladder Dysfunction Reports
- Maria E Rodriguez-Bruno + 5 more
- Research Article
- 10.1007/s11884-025-00788-4
- Nov 12, 2025
- Current Bladder Dysfunction Reports
- Alyssa M Lombardo + 4 more
Abstract Purpose of Review Intermittent catheterization (IC) is widely used for management of urinary retention with a range of supplies, techniques, and complications that need to be considered. This review focuses on more recent literature published in the last 5 years to update readers on current data and guidelines. Recent Findings This article will cover IC technique, outcomes, and troubleshooting that can be applicable to the urologists, advanced practice providers, rehabilitation therapists, nurses, and caregivers. It will focus on management of complications including sediment and stones, urinary incontinence, urethral injury and stricture, and recurrent urinary tract infections (UTI). Patient perceptions of quality of life with IC should be considered and optimized as it is associated with compliance and outcomes. Summary This article has been constructed to serve as a guide for providers of patients who catheterize to aid in supplies selection and patient education with in-depth discussion of technique adaptations and management of complications based on literature published in the last five years.